FREE WEBINAR

An Evidence-Based Approach to Hemp-Derived CBD

Presented by Matt Smith, CEO Med7; Paul Murray, CEO HempCo; Craig Smith, VP Sales Med7

What to expect

WWWWWWWWWW
Hemp-derived CBD products are rapidly saturating the supplement market, both in the United States and globally. Healthcare practitioners and patients alike are finding that labels, definitions, and claims on products in the hemp-derived CBD category tend to be disorganized, lacking standard terminology, and confusing in general. Additionally, there is an expectation for integrative practitioners to understand a rapidly changing market and offer guidance to their patients regarding the use of CBD and hemp extract supplements.

Join our panel of experts to learn about the quickly evolving standards for the cannabinoid supplement industry and the emerging science that guides and supports cannabinoid supplement use. This must-see webinar will cover:

• The differences between hemp, CBD, full-spectrum hemp extract, delta-9-THC, and numerous other cannabinoids

• An in-depth look at varins CBDV and THCV

• Clinical support for cannabinoid supplementation, including NIH-supported studies on Med7
Meet the instructoRs

Matt Smith

WWWWWWWWWW
Matt Smith is the CEO of Med7, a technology-based multinational medical and consumer product company focused on medical industrial hemp. Matt has been the CEO and president of two multinational biotech and nutritional health companies in the US, Japan, and Switzerland. Early in his career, Matt was a results-oriented leader, tactical planner, and sales manager for 15 years at Pfizer Inc.
Patrick Jones - Course author

Paul Murray

WWWWWWWWWW
Paul Murray is the founder and clinical director of Whole Health Centers, multi-modality natural medical clinics in South Denver. Paul is also the CEO of HempCo, a leader in cannabis research and the use of naturally derived, full-spectrum hemp oil for the prevention and improvement of chronic conditions. 
Patrick Jones - Course author

Craig Smith

WWWWWWWWWW
Craig Smith is vice president of sales at Med7. Prior to Med7, Craig was the national sales director at Pfizer in two different divisions. A strong research professional skilled in pharmaceutical sales and sales force development, Craig successfully launched several blockbuster drugs during his 35 years at Pfizer Inc. 
Patrick Jones - Course author